target audience: TECH BUYER Publication date: Nov 2024 - Document type: IDC PeerScape - Doc Document number: # US52683124
IDC PeerScape: Critical Insights for the Implementation of Generative AI in the Life Sciences Industry
Content
List of Figures
Get More
When you purchase this document, the purchase price can be applied to the cost of an annual subscription, giving you access to more research for your investment.
Related Links
Abstract
This IDC PeerScape provides life sciences executives with critical insights related to the challenges faced in implementing generative AI (GenAI) and outlines best practices to guide life sciences companies to drive the successful implementation of life sciences initiatives.
“The life sciences industry is on the move. It is in a hurry to move beyond the POC stage to driving the enterprisewide implementation of use cases demonstrating sustainable business value. ROI is top of mind. But as we are an industry that deals with patient’s lives, ethics and responsible AI frameworks need to be core to the GenAI strategy. Agents are being used to rapidly scale productivity and to humanize the AI experience. Scaling productivity comes first, rapidly followed by disruptive innovation. The life sciences industry is adopting and transforming as we speak. And it is looking to its technology partners to not only provide technology but also guide strategy,” says Dr. Nimita Limaye, research VP, Life Sciences R&D Strategy and Technology at IDC.